Ratio of gross profit to sales for public limited companies in the pharmaceutical industry for the 2014 to 2015 fiscal year
Annual · percent · 2012–2014 · Published by India — Reserve Bank of India
Latest · 2014
25.9%
up +1.3 pts vs 2013
- High since 2012
- 28.3% · 2012
- Low since 2012
- 24.6% · 2013
percent
Use this series in your AI
Use FactIQ to chart rbi::rbi|04a6b0cca48b1c0d over the last ten years, with its latest value and the change over the past year.
The same rows through the SQL tool of the FactIQ plugin or MCP connector.
SELECT time, value
FROM rbi.data_points
WHERE series_id = 'rbi|04a6b0cca48b1c0d'
ORDER BY time;About this series
This series represents the ratio of gross profit, also known as earnings before interest and taxes (EBIT), to total sales for non-government non-financial public limited companies within the pharmaceutical industry. The data is based on historical records from the 2014-15 fiscal year and is part of the Reserve Bank of India's financial ratio analysis for select industries. (Footnote: *=actual ratio; ^=average assets; **=profit-making-company subset; @=two-year-difference derived metric; # and -=missing token)
- Series ID
- rbi::rbi|04a6b0cca48b1c0d
- Frequency
- Annual
- Units
- percent
- Coverage
- 2012 – 2014